Riskpilot← Back to searchSign inGet full accessSALFARM SCANDINAVIA AS
ASActiveOrg 916819277Fridtjof Nansens Plass 4, 0160 OsloVeterinary activities · NACE 7500Est. 20161 employeeswww.salfarm.com
Revenue 2024
NOK 13,4M
+31% vs 2023
EBITDA margin
11.9%
+94% vs 2023
Equity ratio
10.0%
Financial strength
Net profit 2024
NOK 1,1M
+98% vs 2023
| Revenue | NOK 13,4M | +31% |
| EBITDA | NOK 1,6M | +94% |
| Net profit | NOK 1,1M | +98% |
| Total assets | NOK 6,8M | +16% |
| Equity | NOK 676K | -57% |
| Employees | 1 | — |
Legal name
SALFARM SCANDINAVIA AS
Org number
916819277
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
10. mars 2016
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap eller daglig leder og styrets leder i fellesskap.
Company purpose
Salg av veterinær produkter.
Address
Fridtjof Nansens Plass 4, 0160 Oslo
Website
www.salfarm.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 8 745 | 9 298 | 9 352 | 10 251 | 13 443 |
| Staff expenses | −870 | −813 | −1 947 | −1 686 | −1 985 |
| EBITDA | 2 245 | 2 476 | 1 087 | 822 | 1 594 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 2 245 | 2 476 | 1 087 | 822 | 1 594 |
| Net financials | −26 | 118 | −174 | −101 | −169 |
| Profit before tax | 2 219 | 2 594 | 913 | 721 | 1 426 |
| Tax | 488 | 572 | 207 | 158 | 311 |
| Net profit | 1 731 | 2 023 | 706 | 562 | 1 114 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 033 | 4 322 | 3 855 | 5 850 | 6 780 |
| Equity | 271 | 1 294 | 2 000 | 1 562 | 676 |
| Long-term debt | 0 | 2 | 0 | 0 | 0 |
| Short-term debt | 4 762 | 3 026 | 1 855 | 4 288 | 6 104 |
| Total debt | 4 762 | 3 028 | 1 855 | 4 288 | 6 104 |
EBITDA margin
11.9%
This company
15.8%
Market median
-25% vs market
20202024
Equity ratio
10.0%
This company
38.2%
Market median
-74% vs market
20202024
Return on equity
164.8%
This company
18.4%
Market median
+796% vs market
20202024
Net profit margin
8.3%
This company
8.1%
Market median
+2% vs market
20202024
Asset turnover
1.98×
This company
1.12×
Market median
+77% vs market
20202024
Debt / equity
9.03×
This company
0.62×
Market median
-1356% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KA Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
MN Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Former (3) | ||
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2022 – 2025 | |
| Chairman | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Salpharm Holding Aps | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SALFARM SCANDINAVIA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristine Alette Hammervold Steinsland | Chief Executive Officer | 0 companies |
| Mette Nørgaard | Chief Executive Officer | 0 companies |
| Peter Wendorff Olsen | Chairman | 0 companies |
| Sune Fraes Diernæs | Board of Directors | 0 companies |
| Ronnie Møller-Thorsøe | Board of Directors | 0 companies |
| Thomas Bjerregaard Thomsen | Chairman | 0 companies |
| Michael Degn-Mortensen | Board of Directors | 0 companies |